| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 32 |
| 1 | ASPIRIN 325 MG | 32 |
| 2 | ASPIRIN 81 MG | 32 |
| 3 | IBUPROFEN | 19 |
| 4 | IBUPFROFEN | 18 |
| 5 | IBUPROFEN 200 MG | 18 |
| 6 | IBUPROFEN 200MG | 18 |
| 7 | IBUPROFEN CAPSULE | 18 |
| 8 | IBUPROFEN CAPSULES 200 MG | 18 |
| 9 | IBUPROFEN ORAL | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RIFAPENTINE | 2 | 0.0038 |
| 1 | PRAZIQUANTEL | 1 | 0.0033 |
| 2 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 3 | LATANOPROST OPHTHALMIC SOLUTION 0.005% | 1 | 0.0016 |
| 4 | TROPICAMIDE | 2 | 0.0012 |
| 5 | ECONAZOLE NITRATE | 1 | 0.0011 |
| 6 | PEGCETACOPLAN | 2 | 0.0011 |
| 7 | BESIFLOXACIN | 1 | 0.0010 |
| 8 | ACETAMINOPHEN, ASPRIN, CAFFEINE | 7 | 0.0010 |
| 9 | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | 7 | 0.0010 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 32 |
| 2 | Corticosteroid [EPC] | 27 |
| 3 | Platinum-based Drug [EPC] | 15 |
| 4 | Central Nervous System Stimulant [EPC] | 14 |
| 5 | Proton Pump Inhibitor [EPC] | 13 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 13 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | GLP-1 Receptor Agonist [EPC] | 10 |
| 9 | Thiazide Diuretic [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 2 | 0.0006 |
| 1 | Carbonic Anhydrase Inhibitor [EPC] | 9 | 0.0004 |
| 2 | Anthelmintic [EPC] | 1 | 0.0003 |
| 3 | Anticholinergic [EPC] | 4 | 0.0002 |
| 4 | Antiseptic [EPC] | 1 | 0.0002 |
| 5 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 4 | 0.0002 |
| 7 | Central Nervous System Stimulant [EPC] | 14 | 0.0002 |
| 8 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 4 | 0.0002 |
| 9 | Somatostatin Analog [EPC] | 1 | 0.0001 |